7/9/13

Inactive Ingredients in FDA Approved Drugs

FDA Home3 Drug Databases 4 Inactive Ingredient Search

Inactive Ingredient Search for Approved Drug Products

About this Database5 Back to Search Page

Search Results for: "Sodium Lauryl Sulfate"

INACTIVEINGREDIENT6 SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE ROUTE;DOSAGE FORM7 BUCCAL/SUBLINGUAL; TABLET DENTAL; GEL DENTAL; PASTE ORAL; CAPSULE ORAL; CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN ORAL; CAPSULE, DELAYED ACTION ORAL; CAPSULE, DELAYED ACTION, COATED, HARD GELATIN ORAL; CAPSULE, ENTERIC COATED PELLETS ORAL; CAPSULE, EXTENDED RELEASE ORAL; CAPSULE, HARD GELATIN ORAL; CAPSULE, SOFT GELATIN ORAL; CAPSULE, SUSTAINED ACTION ORAL; CAPSULE, SUSTAINED ACTION, HARD GELATIN ORAL; DISPERSIBLE TABLET ORAL; DROPS ORAL; GRANULE ORAL; POWDER, FOR SUSPENSION ORAL; SUSPENSION ORAL; TABLET ORAL; TABLET (IMMED./COMP RELEASE), UNCOATED, HYPODERMIC ORAL; TABLET (IMMED./COMP. RELEASE), COATED ORAL; TABLET (IMMED./COMP. RELEASE), FILM COATED ORAL; TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE ORAL; TABLET, COATED ORAL; TABLET, DELAYED ACTION ORAL; TABLET, DELAYED ACTION, ENTERIC COATED ORAL; TABLET, EXTENDED RELEASE CAS NUMBER8 151213 151213 151213 151213 151213 UNII9 368GB5141J 368GB5141J 368GB5141J 368GB5141J 368GB5141J 15MG 3.6MG MAXIMUM POTENCY 10 1.1MG 1.47%

SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE

151213 151213

368GB5141J 368GB5141J

0.118MG 2MG

SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE

151213 151213 151213 151213 151213 151213

368GB5141J 368GB5141J 368GB5141J 368GB5141J 368GB5141J 368GB5141J

1.004MG 16.667MG 7MG 24MG 9.474MG 1.7MG

SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE

151213 151213 151213 151213 151213 151213 151213

368GB5141J 368GB5141J 368GB5141J 368GB5141J 368GB5141J 368GB5141J 368GB5141J

8.4MG

0.066% 0.15% 51.69MG 28.6MG

SODIUM LAURYL SULFATE

151213

368GB5141J

1MG

SODIUM LAURYL SULFATE

151213

368GB5141J

0.98MG

SODIUM LAURYL SULFATE

151213

368GB5141J

5MG

SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE

151213 151213 151213 151213

368GB5141J 368GB5141J 368GB5141J 368GB5141J

5.2MG 1MG 8.09MG 51.69MG

www.accessdata.fda.gov/scripts/cder/iig/getiigWEB.cfm

1/3

7/9/13
SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE ORAL; TABLET, FILM COATED ORAL; TABLET, MULTILAYER, EXTENDED RELEASE ORAL; TABLET, ORALLY DISINTEGRATING ORAL; TABLET, SUSTAINED ACTION ORAL; TABLET, SUSTAINED ACTION, COATED ORAL-28; TABLET RESPIRATORY (INHALATION); CAPSULE SUBLINGUAL; TABLET TOPICAL; EMULSION, CREAM TOPICAL; LOTION TOPICAL; OINTMENT TOPICAL; SHAMPOO TOPICAL; SHAMPOO, SUSPENSION TOPICAL; SPONGE VAGINAL; CREAM, EMULSION, SUSTAINED RELEASE VAGINAL; EMULSION, CREAM VAGINAL; INSERT

Inactive Ingredients in FDA Approved Drugs

151213 151213 368GB5141J 368GB5141J 12MG 0.8MG

SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE

151213 151213 151213

368GB5141J 368GB5141J 368GB5141J

0.5MG 20.62MG 10.5MG

SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE

151213 151213 151213 151213 151213 151213 151213 151213 151213 151213

368GB5141J 368GB5141J 368GB5141J 368GB5141J 368GB5141J 368GB5141J 368GB5141J 368GB5141J 368GB5141J 368GB5141J

0.65MG

0.02MG 2.5% 0.5% 1% 40%

0.3%

SODIUM LAURYL SULFATE SODIUM LAURYL SULFATE

151213 151213

368GB5141J 368GB5141J

0.333% 5MG

Update Frequency: Quarterly Data Through: March 29, 2013 Database Last Updated: April 12, 2013 Links on this page: 1. http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain 2. http://www.addthis.com/bookmark.php 3. http://www.fda.gov/default.htm 4. http://www.fda.gov/Drugs/InformationOnDrugs/default.htm 5. http://www.fda.gov/Drugs/InformationOnDrugs/ucm080123.htm 6. http://www.fda.gov/Drugs/InformationOnDrugs/ucm075230.htm 7. http://www.fda.gov/Drugs/InformationOnDrugs/ucm075230.htm 8. http://www.fda.gov/Drugs/InformationOnDrugs/ucm075230.htm 9. http://www.fda.gov/Drugs/InformationOnDrugs/ucm075230.htm 10. http://www.fda.gov/Drugs/InformationOnDrugs/ucm075230.htm Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players. Accessibility Contact FDA Careers FDA Basics FOIA No Fear Act Site Map Transparency Website Policies U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 Ph. 1-888-INFO-FDA (1-888-463-6332) Email FDA For Government For Press Combination Products Advisory Committees Science & Research Regulatory Information Safety Emergency Preparedness International Programs News & Events Training and Continuing Education Inspections/Compliance State & Local Officials Consumers Industry Health Professionals FDA Archive

Links on this page:

www.accessdata.fda.gov/scripts/cder/iig/getiigWEB.cfm

2/3

7/9/13
2. http://www.addthis.com/bookmark.php 3. http://www.fda.gov/default.htm

Inactive Ingredients in FDA Approved Drugs

1. http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain

4. http://www.fda.gov/Drugs/InformationOnDrugs/default.htm 5. http://www.fda.gov/Drugs/InformationOnDrugs/ucm080123.htm 6. http://www.fda.gov/Drugs/InformationOnDrugs/ucm075230.htm 7. http://www.fda.gov/Drugs/InformationOnDrugs/ucm075230.htm 8. http://www.fda.gov/Drugs/InformationOnDrugs/ucm075230.htm 9. http://www.fda.gov/Drugs/InformationOnDrugs/ucm075230.htm 10. http://www.fda.gov/Drugs/InformationOnDrugs/ucm075230.htm

www.accessdata.fda.gov/scripts/cder/iig/getiigWEB.cfm

3/3